A Call for a European Prohibition of Monoclonal Antibody Production by the Ascites Procedure in Laboratory Animals

Alternatives to Laboratory Animals

Volumn 26, Issue 4, 1998, Pages 523-540

  Hendriksen, Coenraad F M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Ascites method; In vitro production; In vivo production; Monoclonal antibodies; Replacement alternatives

Indexed keywords

ANIMALIA;

EID: 2542623057     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Köhler, G & Milstein, C (1975). Continuous cultures of fused cells secreting antibody of predefined specificity Nature, London 256, 495-497.
2. Asai, D J & Wilder, J K (1993) Making monoclonal antibodies Methods in Cell Biology 37, 57-74.
3. Anon, (1998) Rabies vaccine inactivated for veterinary use, Monograph Xo 0451 European Pharmacopoeia, Suppl , 445-447 Strasbourg. Council of Europe
4. Lindl, T (1995) Entwicklung humaner monoklonaler Antikorper (Development of human monoclonal antibodies) Alternativen zu Tierexperimenten 12, 13-23.
5. Marx, U , Embleton, M.J., Fischer, R., Gruber, F.P , Hansson. U , Heuer, J , de Leeuw, W A., Logtenberg, T , Merz, W , Portelle, D., Komette, J-L & Straughan, D W (1997) Monoclonal antibody production The report and recommendations of ECVAM workshop 23 ATLA 25, 121-137.
6. Johnson, D.R. (1995). Murine monoclonal antibody development. In Methods in Molecular Biology, Vol. 51, Antibody Engineering Protocols (ed. S Paul), pp. 123-137 Totowa, NJ, USA. Humana Press.
7. Lagace, J & Brodeur, B.R (1985). Parameters affecting in vitro immunization of human lymphocytes. Journal of Immunological Methods 85, 127-136.
8. Borrebaeck, C.A.K., Daniellson, L. & Moller, S.A. (1988). Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes. Proceedings of the National Academy of Sciences USA 85, 3995-3999.
9. Lewin, D.I. (1997) Animal Welfare Group seeks ban on mAbs from mouse ascites The Journal of NIH Research 9, 22-23.
10. Ho, M-K., Rand, N., Murray, J., Kato, K & Rubin, H (1985). In vitro immunization of human lymphocytes. I. Production of human monoclonal antibodies against Bombesin and Tetanus toxoid. Journal of Immunological Methods 135, 3831-3838.
11. Leenaars, P.P.A.M., Koedam, M.A., Wester, P W., Baumans, V., Claassen, E. & Hendriksen, C.P.M. (1998). Assessment of side-effects induced by injection of different adjuvant/antigen combinations in rabbits and mice. Laboratory Animals, in press
12. Abrams, P.G., Ochs, J.J., Giardina, S.L , Morgan, A.C., Wilburn, S.B., Wilt, A R , Oldham, R K. & Foon, K.A. (1984) Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies Journal of Immunology 132, 1611-1613
13. Goettel-Connolly, C (1997) Alternatives in monoclonal antibody production workshop Animal Welfare Information Center Newsletter 8, 21
14. Anon (1997). Antibody "cruelty" to be phased out New Scientist, 2108, 12
15. Kuhlmann, I , Kurth, W & Ruhdel, I (1989). Monoclonal antibodies in vivo and in vitro production on a laboratory scale, with consideration of the legal aspects of animal protection ATLA 17, 73-82.
16. Gillette, R W (1987). Alternatives to pristane priming for ascites fluid and monoclonal antibody production. Journal of Immunological Methods 99, 21-23
17. Pistillo, M P , Sguerso, V & Ferrara, G B (1992) High yields of anti-HLA human monoclonal antibodies can be provided by SCID mice Human Immunology 35, 256-259
18. Stewart, F , Callander, A. & Garwes, D J (1989). Comparison of ascites production for monoclonal antibodies in Balb/c and Balb.c derived cross-bred mice Journal of Immunological Methods 119, 269-275
19. Marx, U & Merz, W (1995) In vivo and in vitro production of monoclonal antibodies Bioreactors versus immune ascites In Methods in Molecular Biology. Vol 45, Monoclonal Antibody Protocols (ed W C Davis). pp 169-176 Totowa, NJ, USA. Humana Press.
20. Sjorgren-Jansson, E , Ohlin, M , Borrebaeck, C A K. & Jeanson. S (1991) Production of human monoclonal antibodies in dialysis tubing Hybridoma 10, 411-419.
21. Fromer, M J (1997) NIH denies petition to ban in vivo mAb production; lawsuit threatened Oncology Times 19, 37-40.
22. Spicer, S.S., Spivey, M A., Ito, M & Schulte, B A (1994) Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones and mast cells. Journal of Histochemistry and Cytochemistry 42, 213-221.
23. Appelmelk, B.J , Verweij-Van Vught, A M , Maaskant, J J , Thijs, L.G & MacLaren, D M. (1992). Murine ascites fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodies Immunological Letters 33, 135-138.
24. McArdle. J (1997) Alternatives to ascites production of monoclonal antibodies. Animal Welfare Information Center Newsletter 8, 1-18
25. Shalev, M. (1998) European and US regulation of monoclonal antibodies. Laboratory Animal 27, 15-17
26. Anon, (1998) Animal Research Review Panel: Monoclonal Antibodies, New South Wales Government, 6pp Sydney ANSW Agriculture
27. Matfield, M. (1997) ECVAM report. monoclonal AB production EBRA Bulletin, August 1997, 9
28. Anon (1994) Richtlinien zur Herstellung von monoklonalen Antikörpern (Guidelines for the production of monoclonal antibodies) Richtlinie Tierschutz 5 01, Liebefeld-Bern. Bundesamt fur Veterinarwesen
29. Falkenberg, F W , Hengelage, T , Krane, M , Bartels, I., Albrecht, A , Holtmeier, N & Wuthrich, M (1993). A simple and inexpensive high density dialysis tubing cell culture system for the in vitro production of monoclonal antibodies in high concentrations Journal of Immunological Methods 165, 193-206
30. Falkenberg, F W , Weichert, H , Krane, M., Bartels, I., Palme, M , Nagels, H O & Fiebig, H. (1995) In vitro production of monoclonal antibodies in high concentrations in a new and easy to handle modular minifermentor Journal of Immunological Methods 179, 13-29
31. 2 incubator Cytotechnology 14, 1-9
32. Pannell, R & Milstein, C (1992) An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascites tumours. Journal of Immunological Methods 146, 43-48
33. Jackson, L R., Trudel, L J , Fox, J G & Lipman, NS (1996) Evaluation of hollow fibre bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production Journal of Immunological Methods 189, 217-231
34. Pesson, B & Emborg, C (1992) A comparison of three different mammalian cell bioreactors for the production of monoclonal antibodies. Bioprocess Engineering 8, 157-163
35. Fischer, R.W & Ferber, P C (1992) Monoklonale Antikorper: In vitro-Produktionsmethoden im Vergleich. (Monoclonal antibodies. comparison of in vitro methods) Alternativen zu Tierexperimenten 16, 15-24
36. Van der Kamp, M & de Leeuw, W (1996) Short review of in vitro production methods for monoclonal antibodies NCA Newsletter 3, 10-11.
37. Van der Velden-de Groot, C A.M. (1990). Monoclonale antistoffen Produktie in vivo oder in vitro. (Production of monoclonal antibodies. Production in vivo or in vitro.) Biotechniek 29, 73-74.
38. Kurkela, R., Fraune, E & Vihko, P. (1993) Pilotscale production of murine monoclonal antibodies in agitated, ceramic-matrix of hollow-fiber cell culture systems. BioTechniques 15, 674-683.
39. Chirbik, R.J., Rosen, S.M , Trunfio, D.M., Fischberg-Bender, E.W & Palmer, S.M. (1996). Factors affecting antibody production efficiency in hollow-fiber bioreactors IVD Technology Magazine Web site. http://www.devicelink.com/ivdt/ archive/96/07/007 html.
40. Lowrey, D., Murphy, S. & Goffe, R.A. (1994). A comparison of monoclonal antibody productivity in different hollow fibre bioreactors. Journal of Biotechnology 36, 35-38.
41. Anon. (1997). "Alternatives in Monoclonal Antibody Production" a workshop of The John Hopkins Center for Alternatives to Animal Testing and The Office for Protection from Research Risks, National Institute of Health, Baltimore, MD, USA, 24-25 September 1997, Web site. http.//wwwsphjhu.edu/∼altweb/science/meetings/mab/proceedings.htm.
42. Kagan, E Vieira, E & Petrie, H.T. (1997) Comparison of hollow fiber bioreactors and modular minifermentors for the production of large numbers of monoclonal antibodies in vitro. In "Alternatives in Monoclonal Antibody Production", a workshop of The John Hopkins Center for Alternatives to Animal testing and The Office for Protection from Research Risks, National Institutes of Health, Baltimore, MD, 24-25 September Web site httpwwwsphjhuedu/∼altweb/science/ meetings/mab/proceedings/htm.
43. Jochems, C (1997) Use, Trade and Harvest of Livestock Sera Thesis, Utrecht University
44. Fike, R-M , Jayme, D W & Weiss, S A (1991) Monoclonal antibody enhancement in protein-free and serum-supplemented hybridoma culture media American Biotechnology Laboratory 9, 40-42
45. Goodall, M (1997) Production of monoclonal antibodies. in vivo versus in vitro methods In Animal Alternative, Welfare & Ethics (ed L F M. van Zutphen & M Balls), pp 965-972 Amsterdam, Elsevier
46. Patel, P T , Parekh, R B, Moellering, B.J & Prior, C P (1992) Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody Biochemical Journal 285, 839-845
47. Stoll, T , Ruffleux, P-A , Lullau, E , von Stockar, U & Marison, I W (1995) Production of immunoglobulin A in different reactor configurations Cytotechnology 11, 608-614
48. De Kruif, J , Van der Vuurst de Wries, A R , Cilenti, L , Boel, E , Van Ewijk, W C. & Logtenberg, T (1996) New perspectives on recombinant human antibodies Immunology Today 17, 453-455.
49. Devlin, J.J , Panganiban, L.C. & Devlin, P.E. (1990) Random peptide libraries: a source of specific protein binding molecules. Science, New York 249, 404-406.
50. Ma, J K-C , Hiatt, A., Hein, M., Vine, N.D., Wang, F., Stabila, P., van Dolleweerd, C., Mostov, K. & Lehner, T. (1995). Generation and assembly of secretory antibodies in plants. Science, New York 268, 716.
51. Carayannopoulos, L., Max, E.E. & Capra, J.D. (1994). Recombinant human IgA expressed in insect cells. Proceedings of the National Academy of Sciences USA 91, 8348-8352.
52. Plueckthun, A. (1992). Mono and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding. Immunological Reviews 130, 151-188.
53. Eldin, P., Pauza, M.E., Hieda, Y., Lin, G., Murtaugh, M.P., Pentel, P.R. & Pennell, C.A. (1997). High level secretion of two antibody single chain Fv fragments by Pichia pastoris. Journal of Immunological Methods 201, 67-75.
54. Anon (1997). Supplementary Note to the Home Secretary's response to the Animal Procedures Committee Interim Report on the Review of the Operation of the Animals (Scientific Procedure) Act 1986, 6pp. London: HMSO.
55. Ellis, G.B. & Garnett, N.L (1997). Production of monoclonal antibodies using mouse ascites method. Animal Welfare Information Center Newsletter 8, 19
56. Schulhof, J & Lamborn, C. (1998). Jumping from the Banned Wagon. Laboratory Animals 27, 9.
57. Anon (1986) Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes Official Journal of the European Communities L358, 1-29
58. Anon (1986) European Convention for the Protection of Vertebrate Animals Used for Experimental and Scientific Purposes, 51 pp, Strasbourg: Council of Europe
59. Anon (1993) Tierschutzbericht 1993. Drucksache 12/4242, pp. 49-50 Bonn Bundesministerium für Ernahrung, Landwirtschaft und Forsten
60. Anon (1989) Code of Practice for the Production of Monoclonal Antibodies. 6pp Rijswijk, The Netherlands Veterinary Public Health Inspectorate
61. Anon (1994) General recommendations of the National Board for Laboratory Animals on the treatment of certain matters relating to ethical reviews of the use of animals for scientific purposes (LSFS, Statute Book of the National Board of Agriculture/1990 21, Subject no L29) In Provisions and General Recommendations Relating to the Use af Animals for Scientific Purposes (ed O Lundgren), pp 43-46 Stockholm. Karl Olov Osier
62. Anon (1992) Report of the Animal Procedures Committee for 1991, Appendix II, Cmnd 2048, 37pp , London. HMSO